Latest News

Severe obesity ups risk for death in younger men with COVID-19


 

Risk stratified by age and sex

Further analysis showed that, “most strikingly,” among patients aged 60 and younger, those with moderately severe obesity and extremely severe obesity had significant 17-fold and 12-fold higher risks of dying during follow-up, respectively, compared with patients of normal weight, the researchers reported.

In patients older than 60, moderately severe obesity did not confer a significant increased risk for imminent death from COVID-19; extremely severe obesity conferred a smaller, threefold increased risk for this.

“Our finding that severe obesity, particularly among younger patients, eclipses the mortality risk posed by other obesity-related conditions, such as history of myocardial infarction (MI), diabetes, hypertension, or hyperlipidemia, suggests a significant pathophysiologic link between excess adiposity and severe COVID-19 illness,” the researchers noted.

This independent increased risk for death with severe obesity was seen in men but not in women.

Men with moderately severe and extremely severe obesity had significant 4.8-fold and 10-fold higher risks of dying within 3 weeks, respectively, compared with men of normal weight.

“That the risks are higher in younger patients is probably not because obesity is particularly damaging in this age group; it is more likely that other serious comorbidities that evolve later in life take over as dominant risk factors,” Dr. Kass suggested in his editorial.

“That males are particularly affected may reflect their greater visceral adiposity over females, given that this fat is notably proinflammatory and contributes to metabolic and vascular disease,” he added.

“As a cardiologist who studies heart failure,” Dr. Kass wrote, “I am struck by how many of the mechanisms that are mentioned in reviews of obesity risk and heart disease are also mentioned in reviews of obesity and COVID-19.”

The study was funded by Roche-Genentech. Kass has disclosed no relevant financial relationships. Disclosures of the authors are listed in the article.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Sleeve gastrectomy, antiobesity drugs underutilized
Federal Practitioner
Health care costs nearly doubled for patients with NAFLD
Federal Practitioner
Bariatric surgery in advanced heart failure wins transplant eligibility
Federal Practitioner
COVID-19 triggers new bariatric/metabolic surgery guidance
Federal Practitioner
Weight loss stays consistent in one- and two-step in gastric band conversion
Federal Practitioner
Older adults boost muscle mass after bariatric surgery
Federal Practitioner
Intermittent fasting ‘not benign’ for patients with diabetes
Federal Practitioner
Even mild obesity raises severe COVID-19 risks
Federal Practitioner
How high a priority is bariatric surgery during COVID-19?
Federal Practitioner
AHA statement recommends dietary screening at routine checkups
Federal Practitioner